LUBOV HORNIACEK: Open Payments
NPI 1770863250 · BELLEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$705 in 29 payments from 10 companies in 2025. Trend: 2023 $646 · 2024 $519 · 2025 $705
Food & beverage: $705
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 12 | $138 |
| Edwards Lifesciences Corporation | 1 | $135 |
| Abbott Laboratories | 4 | $91 |
| AstraZeneca Pharmaceuticals LP | 1 | $86 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $64 |
| Boston Scientific Corporation | 1 | $60 |
| ABIOMED | 2 | $55 |
| CVRx, Inc. | 3 | $47 |
| PFIZER INC. | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: Assure WCD, SAPIEN 3 Ultra RESILIA, WAINUA, LifeVest, WATCHMAN FLX, Barostim Neo System, JOT DX, AVEIR.
Industry payments across NJ — which companies pay providers there.
